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Abstract
Despite the subjective nature of pain experience with cognitive and affective dimensions, preclinical pain research
has largely focused on its sensory dimension. Here, we examined the relationship between learning/memory and
nociceptive behavior in rats with combined learning impairment and persistent nociception. Learning impairment was
induced by bilateral hippocampal injection of a mixed Aβ solution, whereas persistent nociception produced in these
rats by complete Freund’s adjuvant-induced ankle inflammation. Those rats with learning impairment showed a
diminished development of thermal hyperalgesia and mechanical allodynia and a shorter time course of nociceptive
behavior without alteration of their baseline nociceptive threshold. In rats with pre-established hyperalgesia and
allodynia due to ankle inflammation, bilateral intra-hippocampal injection of cycloheximide (a protein synthesis
inhibitor) promoted the earlier recovery of nociceptive behavior. Moreover, expression of Aβ, NR1 subunit of the N-
methyl-D-aspartate receptor, and protein kinase Cγ was upregulated, whereas the choline acetyl transferase
expression was downregulated, in the hippocampus, thalamus, amygdala, and/or spinal cord of rats with combined
learning impairment and persistent nociception. The data indicate that learning impairment could disrupt the
response to a state of persistent nociception, suggesting an important role for cognitive maladaptation in the
mechanisms of chronic pain. These results also suggest that a preclinical model of combined learning impairment
and persistent nociception may be useful to explore the brain mechanisms underlying the transition from acute to
chronic pain.
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Introduction
Pain is a complex subjective experience with sensory-
discriminative, motivational-affective, cognitive-evaluative
dimensions [1,2]. To date, most studies of pain mechanisms
have focused on the sensory-discriminative dimension of pain,
while less is known regarding the relationship between the
cognitive function and pain perception and its role in the
transition from acute to chronic pain [3–5]. Clinically, an
increasing body of evidence has indicated that pain perception
may be altered in patients with dementia such as Alzheimer’s
disease (AD) [6,7], an irreversible neurodegenerative disease
characterized by the deposition of different forms of beta-
amyloid (Aβ) in the brain, cognitive impairment, and memory
loss [8,9]. In the clinical setting, AD patients have been shown
to receive fewer analgesics possibly because they report less
pain than those with intact cognitive function but similar pain
conditions [10,11]. These findings are consistent with a
neuroimaging study showing the role of brain structures in
retrieving autobiographical memories of painful events [12].
Since pain assessment in patients with cognitive and
learning impairment is complex [3,13], clinical studies often
exclude such patients from participation [14]. Indeed, current
pain assessment tools are inadequate to capture the impact of
cognitive and learning dysfunction on pain perception, often
resulting in under-treatment of pain in patients with cognitive
and learning impairment [15–18]. In the present study, we
sought to examine a relationship between learning impairment
and pain using a combined rat model. In the first experiment,
we examined whether learning impairment would be
associated with diminished nociceptive behaviors. In the
second experiment, we investigated whether disrupting the
PLOS ONE | www.plosone.org 1 September 2013 | Volume 8 | Issue 9 | e74533
function of learning and memory by intra-hippocampal
administration of cycloheximide, a protein synthesis inhibitor
shown to disrupt memory formation and consolidation [19],
would alter the recovery time of pre-established nociceptive
behaviors.
Materials and Methods
Experimental animals
Male Sprague-Dawley rats weighing 250-300g (Charles
River Lab, Wilmington, MA) were used. The animal room was
12h dark/light cycle with lights on from 7AM to 7PM. All animals
had ad libitum access to water and a standard rat diet. The
experimental protocol was approved by the Massachusetts
General Hospital Institutional Animal Care and Use Committee.
Induced learning impairment
Aβ1-40 and Aβ1-42 powders (Sigma, 600 µg, 1:1) were
dissolved in 300µl sterile artificial cerebrospinal fluid (ACSF)
with 1% NH4OH. The solution was then mixed and centrifuged
at 15000×g for 5min to a final concentration of 2µg/µl, which
was incubated at 37°C for 6 days to form a mature Aβ solution
before its final use.
To inject the Aβ solution into the hippocampal CA1 area, a
surgical procedure was performed under sodium pentobarbital
(50mg/kg i.p.) anesthesia [20]. A rat was placed onto a
stereotaxic frame. The scalp was shaved and sterilized with a
beta-dine solution and alcohol and a 1.0cm midline sagittal
incision was made to expose the skull. For microinjection,
holes (OD 0.6mm) were drilled through the skull (3.3mm
posterior to Bregma, 1.6mm lateral to the midline) according to
the rat’s brain atlas of Paxinos and Watson [21]. The mixed Aβ
solution (10µg/5µl) was injected slowly (0.5µl/min) into the
bilateral hippocampal CA1 area (2.8mm ventral to the brain
surface) using a 5-µl microsyringe (Hamilton). The needle was
left in place for 10min after the injection for solution dispersion
before being slowly withdrawn. The hole on the skull was
closed with bone wax (ETHICON). The skin wound was applied
with antibiotic to prevent infection and closed with wound clips.
Sham control rats underwent the same procedure except that
sterile ACSF was injected with the same volume as the Aβ
solution. Naïve rats did not undergo the surgical procedure, nor
received any injection. The location of the intra-hippocampal
injection was confirmed at the time of tissue harvest and with
immunostaining. Rats with an incorrect injection site and the
lack of learning impairment were excluded from final
experiment data analysis.
Ankle joint inflammation
Ankle inflammation was induced by injecting 50µl of
complete Freund’s adjuvant (CFA, Sigma) into the right tibio-
tarsal joint under 2% isoflurane anesthesia [22]. The right hind
paw was held and the fossa of the lateral malleolus of the fibula
was located. A 22-gauge needle was inserted vertically to enter
the articular cavity between the tibio-fibular and tarsus bone
until a loss of resistance was felt. For sham control, incomplete
Freund’s adjuvant (IFA, Sigma, as vehicle of CFA) was injected
with the same volume and approach. Naïve control rats
received neither CFA nor IFA. Both ankles of rats from CFA
and IFA groups were inspected after the injection. The
inflammation was indicated by redness and swelling of the
injected ankle as well as nociceptive behavior (see below), as
compared with the contralateral non-injected hind paw.
Behavioral tests
Morris water maze task.  A standard water maze task was
used with minor modifications [23]. A circular pool (1.3m in
diameter and 75cm in depth) was partially filled with milked
water of 25 ± 1°C and 30cm in depth. A rat was able to rest for
30 s once it found and climbed onto a platform (12cm×12cm).
Both hidden-platform test and visible-platform test were
carried out. The hidden-platform test was carried out on day 8
after the intra-hippocampal Aβ injection (designated as day 1).
The process consisted of two trials per day for 5d. During each
trial, rats were released from four assigned starting points and
allowed to swim for a maximum of 120s. The time elapsed
before a rat climbed onto the platform submerged 1cm below
the water surface and located in the middle of the southeast
quadrant of the water pool (i.e., escape latency from the maze)
was recorded. If a rat failed to find the platform in 120s, it would
be led to the platform and also allowed to stay for 30s. To rule
out the impact of a non-specific effect on the Morris water
maze test, the visible-platform test was performed on day 7
and 8 (i.e., days 14 and 15 after the Aβ injection). For this test,
the platform was elevated 1cm above the water surface but
placed in a different site away from that used for the hidden-
platform test. Similarly, the time required to escape onto the
visible platform (i.e., escape latency) was recorded. In all tests,
rats were placed into the pool facing the wall at the beginning
of each trial.
Locomotor activity.  A rat was placed on a floor and any
gait abnormalities were assessed and recorded using the
method of Chatani et al. [24]: 0, normal; 1, slightly limping; 2,
clearly limping but useful in walking; 3, severely limping and not
useful in walking.
Thermal hyperalgesia and mechanical allodynia.  Two
daily 60-min sessions were used to habituate rats to the test
environment. The withdrawn latency (in seconds) to thermal
stimulation and withdrawal threshold (in grams) to mechanical
stimulation were examined for both ipsilateral and contralateral
hind paws before (baseline) and at 1, 3, 5, 7, and 14 days after
CFA or IFA injection. The thermal hyperalgesia test was
performed using the method of Hargreaves et al. [25]. The
radiant heat source was adjusted to result in baseline latencies
of around 12s and a cut-off latency of 20s. Two trials were
performed on each hind paw with a 5min interval. A set of von
Frey filaments was used to measure mechanical allodynia
using an up-and-down method [26]. Rats were individually
placed in a plastic box with a wire mesh floor. A single von Frey
fiber was applied to the plantar surface for five times with an
inter-stimulation interval of 5s. A positive response was defined
as at least one clear paw withdrawal response out of the five
applications [26]. All behavioral tests were carried out between
9 AM and noon.
Nociceptive Behavior and Leaning Impairment
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Immunohistochemistry
Rats were deeply anesthetized with sodium pentobarbital
(60mg/kg i.p.), perfused transcardially with 0.9% saline
followed by 4% paraformaldehyde in 0.1M phosphate buffer
(pH7.4, 4°C), brain and lumbar spinal cord segments were
removed, post-fixed overnight 4°C, then cryoprotected in 30%
sucrose in 0.1M phosphate buffer saline (PBS) at 4°C until
tissue blocks sank to the bottom. Sections (brain: 40µm; spinal
cord: 25µm) were cut using a cryostat and washed with 0.01M
PBS for 10min×3, blocked for 1h in PBS containing 1% BSA,
0.3% Triton X-100 at room temperature, and then incubated for
overnight at 4°C with one of the following primary antibodies:
Beta-amyloid (Abcam): 1:500, rabbit polyclonal; NR1 receptor -
NR1 (Abcam): 1:500, rabbit polyclonal; protein kinase Cγ-
PKCγ (Abcam): 1:500, rabbit polyclonal; choline acetyl
transferase - ChAT (Chemicon; Millipore): 1:100, rabbit
polyclonal. Sections were incubated for 1h at room temperature
with FITC- or Cy3-conjugated secondary antibody (1:300;
Chemicon, Temecula, CA) and then washed with PBS for
10min×3. For controls, primary antibody was omitted. Sections
were examined with a fluorescence microscope (Olympus,
Japan), and images were captured with a digital camera and
analyzed with Adobe Photoshop version 7.0.
Western Blot
Rats were sacrificed by decapitation under sodium
pentobarbital anesthesia (60 mg/kg i.p.). Brain (hippocampus,
amygdala, and thalamus) and spinal cord samples, which were
divided into ipsilateral and contralateral side, were removed
and rapidly frozen on dry ice and stored at -80°C until use.
Samples were homogenized in SDS buffer containing a mixture
of protease inhibitors (Sigma). Protein samples were prepared
on SDS-PAGE gels (4-15% gradient gel) and transferred to
polyvinylidene difluoride membranes (Millipore). Membranes
were blocked with 5% non-fat dried milk for 1h at room
temperature and incubated overnight at 4°C with one of the
following primary antibodies: Beta-amyloid (Abcam): 1:500,
rabbit polyclonal; NR1 (Abcam): 1:1000, rabbit polyclonal;
PKCγ (Abcam): 1:250, rabbit polyclonal; ChAT (Chemicon;
Millipore): 1:4000, rabbit polyclonal. Membranes were
incubated for 1h at room temperature with HRP-conjugated
secondary antibody (1:8000; Amersham Biosciences, Arlington
Heights, IL). Blots were visualized in ECL solution (NEN,
Boston, MA) for 2min and exposed to hyperfilms (Amersham
Biosciences) for 0.5-10min. Blots were again incubated in
stripping solution (67.5mM Tris, pH 6.8, 2% SDS, and 0.7% β-
mercaptoethanol) for 30 min at 50°C and reprobed with anti-β-
actin antibody (1:12000, mouse monoclonal; Abcam) as
loading control. All western blot analyses were made in
triplicates.
Experimental design
Experiment 1.  (Figure 1A) To examine the effect of learning
impairment on the development of nociceptive behavior, the Aβ
or ACSF solution was first injected into the bilateral CA1 area
of the hippocampus. The Morris water maze test began on day
8 (designated as test day 1) after the hippocampal injection to
examine whether learning impairment was induced. The Morris
water maze test consisted of two paradigms: 1) the hidden-
platform test was carried out over 5 daily sessions from test
day 1 to 5, and 2) the visible-platform test was performed in on
test day 7 and 8 to rule out non-specific effects. On day 15
after the initial intra-hippocampal injection (i.e., after the last
water maze test), either CFA or IFA was injected into the right
ankle joint after obtaining the baseline thermal and mechanical
nociceptive threshold. The test for nociceptive behavior was
then made on day 1, 3, 5, 7, and 14 after the CFA or IFA
injection. Accordingly, a total of five experimental groups were
included (n=6): Naïve group (no hippocampus or ankle
injection), ACSF (hippocampus)/vehicle (ankle) group, ACSF
(hippocampus)/CFA (ankle) group, Aβ (hippocampus)/vehicle
(ankle) group, and Aβ (hippocampus)/CFA (ankle) group. After
the final behavioral test, the Morris water maze test was
repeated to confirm the continuing presence of induced
learning impairment.
Experiment 2.  (Figure 1B) To examine the effect of learning
impairment on the recovery of nociceptive behavior,
cycloheximide (1% DMSO in saline; Sigma-Aldrich) was
injected into the hippocampus according to the following
experimental protocol. Rats first received the CFA (50µl)
injection into the right ankle joint and the nociceptive behavioral
test was performed on day 0 (baseline) and post-CFA injection
day 1 (designated as day -1), 3 (day -3), and 5 (day -5). On day
0 (i.e., 5 days after the CFA injection), these rats were divided
into 2 subgroups (n=6) and received either cycloheximide (30
µg/5µl) or vehicle (5µl) into the bilateral hippocampal CA1 area.
After the cycloheximide or vehicle injection, the nociceptive test
was repeated on day 1, 3, 5, 9, 13, 17, 19 to compare the time
course for the recovery of nociceptive behavior between the
cycloheximide and vehicle group.
To confirm the effect of cycloheximide on learning and
memory, a group of naïve rats without ankle joint inflammation
was used. Rats in this group first underwent the Morris water
maze test from day 1 to day 5 (designated as day -1 to -5). On
day 0, these rats were divided into 2 subgroups (n=6) and
received either cycloheximide (30 µg/5µl) or vehicle (5µl) into
the bilateral hippocampal CA1 area. After the cycloheximide or
vehicle injection, two more series of the Morris water maze test
(5 sessions per series) were performed on day 1 to day 5 and
day 15 to day 19 to determine the effect of cycloheximide on
the performance of the Morris water maze task. All behavioral
tests were carried out during a similar time period on each test
day for all groups by an observer who was blinded to the group
assignment.
Statistical analysis
The data from the nociceptive behavioral test was first
analyzed using repeated measure two-way ANOVA (group by
time) to detect overall significance among groups using SPSS
16.0 for Windows. The post hoc Tukey test was performed to
detect the source of differences among groups. For Western
blot, the density of each band was measured using Photoshop
and Quantity One and normalized against the corresponding
loading control and the group difference was compared using
one-way ANOVA. For the Morris water maze, one-way ANOVA
Nociceptive Behavior and Leaning Impairment
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or Student t-test was used to detect the group difference. The
data are presented as mean± SD (standard deviation).
Results
Impaired acquisition of spatial learning by the
hippocampal Aβ injection
The effect of the hippocampal Aβ injection on acquisition of
spatial learning was tested by the Morris water maze. While no
differences were detected among three groups in the hidden-
platform test on day 1 and day 2, rats in the Aβ group showed
a significantly longer escape latency than rats in ACSF group
on day 3-5 and in ACSF and naïve groups on day 4-5 (Figure
2A, P < 0.01).
Results from two additional tests indicated that the prolonged
escape latencies in the hidden-platform test for rats in the Aβ
group were due to a learning impairment because 1) rats in the
Aβ group had moderately increased latencies to reach a target
quadrant in the water pool during a probe test as compared
with rats in the ACSF and naive groups (data not shown), and
2) the escape latencies in the visible-platform test on day 7 and
day 8 did not differ among rats in all three groups (P>0.05). In
addition, rats in all three groups exhibited normal gait (scored
0) throughout the experimental period without any indication of
locomotor dysfunction or poor swimming performance.
Immunohistochemical examination of the hippocampal CA1
area showed a substantially increased reactivity of Aβ1-40/1-42
in the Aβ group when examined after the last Morris water
maze test (Figure 2B). In contrast, Aβ immunoreactivity was
barely detectable in rats from the naïve and ACSF groups at
the same hippocampal area (Figure 2B). Western blot also
showed a significant increase in the Aβ expression on the
contralateral (to CFA-injection) hippocampus of rats receiving
both Aβ injection and ankle inflammation as compared with
naïve rats and rats with ACSF injection with or without
inflammation (Figure 2C, P < 0.05). Moreover, the Aβ
expression was also significantly increased in the ipsilateral (to
CFA-injection) hippocampus in rats receiving both Aβ and CFA
injection as compared with naïve rats (Figure 2C, P < 0.05).
Collectively, the combined morphological and behavioral
data indicate that the intra-hippocampal Aβ injection induced
the upregulated Aβ expression and the impairment of spatial
learning in these rats.
Attenuation of the development of nociceptive behavior
in rats with learning impairment
The baseline nociceptive threshold to radiant heat or
mechanical (von Frey filament) stimulation did not differ among
all groups of rats with or without learning impairment. Thermal
hyperalgesia was detected on the ipsilateral hind paw on day 1
after CFA injection in both Aβ and ACSF groups, as compared
with rats without ankle inflammation (naïve or vehicle group)
(Figure 3A, P < 0.05). In those rats with Aβ-induced learning
impairment, thermal hyperalgesia was no longer detectable on
day 3 after CFA injection and throughout the remaining
experimental period (Figure 3A, P > 0.05). In contrast, thermal
hyperalgesia continued to be present over the next two weeks
in those rats without learning impairment (Figure 3A, P < 0.05).
Similar results were obtained in the mechanical allodynia test
such that rats with learning impairment showed a substantially
earlier return to the baseline beginning on day 3 after CFA
injection as compared with the rats without learning impairment
(Figure 3C, P < 0.05). No significant differences in the thermal
and mechanical nociceptive threshold were observed on the
contralateral hind paw among all groups of rats during the
experimental period (Figure 3B,D, P>0.05). Collectively, the
data indicate that the development of nociceptive behavior
(thermal hyperalgesia and mechanical allodynia) was
attenuated in those rats exhibiting learning impairment.
Expression of ChAT in the hippocampus, thalamus,
and amygdala
Choline acetyl transferase (ChAT) is a cholinergic marker
protein for the functional state of cholinergic neurons and its
Figure 1.  A schematic presentation of experimental designs.  A) Experiment 1 examined the effect of intra-hippocampal Aβ-
induced learning impairment on the development of nociceptive behavior following ankle inflammation. B) Experiment 2 examined
the effect of intra-hippocampal cycloheximide on the recovery of established nociceptive behavior following ankle inflammation.
doi: 10.1371/journal.pone.0074533.g001
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deficit has been associated with conditions of learning
impairment seen in AD [27]. Consistently, ChAT
immunoreactivity was decreased in the hippocampus
contralateral to the inflamed ankle in Aβ group as compared
with both naïve and ACSF groups with or without ankle
inflammation (Figure 4A). Western blot results also showed a
substantial downregulation of ChAT expression on contralateral
hippocampus, thalamus, and amygdala of rats in Aβ group with
Figure 2.  Morris water maze test and hippocampal Aβ expression.  A) No differences were detected among three groups of
rats in the hidden-platform test on day 1 and day 2. However, rats in Aβ group showed a longer escape latency than rats in ACSF
group on days 3-5 and rats in naïve group on day 4-5. ** P<0.01, as compared with ACSF group; # P<0.01, as compared with both
naïve and ACSF groups. In contrast, no differences in the escape time in visible-platform test on day 7 and 8. B)
Immunohistochemical examination of the hippocampal CA1 area showed a substantially increased reactivity of Aβ1-40/1-42 in Aβ
group, whereas Aβ immunoreactivity was barely detectable in rats of naïve and ACSF groups at the same hippocampal site. Scale
bar: 100 µm. C) Western blot revealed a significant increase in Aβ expression in hippocampus contralateral to ankle inflammation in
rats receiving Aβ injection with or without ankle inflammation. * P<0.05, as compared with contralateral (contra) side of other groups;
#P<0.05, as compared with ipsilateral (ipsi) side of remaining groups.
doi: 10.1371/journal.pone.0074533.g002
Nociceptive Behavior and Leaning Impairment
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ankle inflammation, as compared with naïve and/or ACSF
groups with or without inflammation (Figure 4B,C, each
P<0.05).
Expression of NR1 and PKCγ in the spinal cord and
brain regions
NR1 and PKCγ have been shown to regulate nociceptive
behavior [28]. In rats with intra-hippocampal Aβ injection, the
expression of NR1 (Figure 5A,B,C) and PKCγ (Figure 6A,B,C)
was upregulated in the hippocampus ipsilateral to ankle
inflammation as compared to Aβ-injected rats without ankle
inflammation (each P<0.05). In these same Aβ-injected rats,
NR1 (Figure 5B,C) and PKCγ (Figure 6B,C) expression was
downregulated on the ipsilateral thalamus, but not amygdala,
as compared to Aβ-injected rats without ankle inflammation
(each P<0.05). In addition, the expression of PKCγ was
increased within spinal cord dorsal horn ipsilateral to ankle
inflammation in both intra-hippocampal Aβ- or vehicle-injected
rats (Figure 6B,C, P<0.05). These results indicate that ankle
inflammation altered the expression of NR1 and PKCγ within
brain regions and that spinal cord dorsal horn implicated in the
nociceptive processing and the function of learning and
memory.
Disruption of persistent nociceptive behavior by intra-
hippocampal injection of cycloheximide
Thermal hyperalgesia and mechanical allodynia were
developed on the ipsilateral hind paw of CFA-injected rats
when tested over a 5-day period (designated as day -1 to -5)
after CFA injection, as compared with their own baseline
(Figure 7A,C, P<0.05). To examine whether impairment of
learning and memory would influence the recovery of
established thermal hyperalgesia and mechanical allodynia,
cycloheximide or vehicle was injected into the hippocampal
CA1 area and thermal hyperalgesia and mechanical allodynia
were again examined on post-injection day 1, 3, 5, 9, 13, 17,
Figure 3.  Attenuated nociceptive behavior in rats with learning impairment.  A, C) The development of thermal hyperalgesia
(A) and mechanical allodynia (C) was attenuated in Aβ-injected rats. B, D) No differences were detected in thermal (B) and
mechanical (D) nociceptive threshold on contralateral hind paw in all groups. * P<0.05, ** P<0.01, as compared with baseline
threshold of the same group. FWL: foot-withdrawal latency. #<0.05, # # P<0.01, as compared with each of the remaining groups at
the same time point.
doi: 10.1371/journal.pone.0074533.g003
Nociceptive Behavior and Leaning Impairment
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and 19. Rats treated with cycloheximide showed a quick
recovery of both thermal hyperalgesia and mechanical
allodynia beginning on day 1 after the cycloheximide injection,
as compared to each corresponding baseline (Figure 7A,C,
P<0.05). In contrast, the recovery of thermal hyperalgesia and
mechanical allodynia did not occur in the vehicle group until
post-injection day 9, as compared to each corresponding
baseline (Figure 7A,C, P<0.05). Neither cycloheximide nor
vehicle injection into the hippocampus impaired locomotor
activity.
The effect of intra-hippocampal cycloheximide injection on
the recovery of thermal hyperalgesia and mechanical allodynia
Figure 4.  Expression of ChAT in the hippocampus, thalamus, and amygdala.  A) ChAT immunoreactivity was decreased in the
hippocampus contralateral to ankle inflammation in Aβ group as compared with both naïve and ACSF groups with or without ankle
inflammation. Veh: Vehicle. Scale bar: 100 µm. B, C) Western blot showed a substantial downregulation of ChAT expression in the
contralateral hippocampus, thalamus, and amygdala of rats in Aβ group with ankle inflammation. * P<0.05, as compared with Aβ/
vehicle and Aβ/CFA groups; # P<0.05, as compared with the ASCF/vehicle group.
doi: 10.1371/journal.pone.0074533.g004
Nociceptive Behavior and Leaning Impairment
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was not due to an altered baseline thermal or mechanical
nociceptive threshold, because no differences in nociceptive
threshold were detected between cycloheximide and vehicle
groups on the contralateral hind paw of these same rats over
the entire experimental period (Figure 7B,D, P>0.05). However,
the same intra-hippocampal cycloheximide injection disrupted
the established spatial learning in a parallel group of rats
without ankle inflammation as demonstrated in two separate
series of the Morris water maze test (post-injection day 1-5 and
post-injection day 15-19), as compared with intra-hippocampal
vehicle group (Figure 8 P<0.05). Therefore, this early recovery
of thermal hyperalgesia and mechanical allodynia in rats
treated with cycloheximide is likely related to the impaired
cognitive response similar to that seen in Experiment 1
following the intra-hippocampal Aβ injection.
Figure 5.  Expression of NR1 in brain regions.  A–C) Immunostaining (A) and Western blot (B, C) showed an upregulation of
NR1 on the ipsilateral side (to ankle inflammation) of the hippocampus in rats with the intra-hippocampal Aβ injection. Scale bar:
100 µm. B, C) In these same Aβ-injected rats, NR1 expression was downregulated in the ipsilateral thalamus but not amygdala. *
P<0.05 and ** P<0.01, as compared with the naïve and ACSF group on the same (ipsilateral) side.
doi: 10.1371/journal.pone.0074533.g005
Nociceptive Behavior and Leaning Impairment
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Discussion
We conducted two experiments to examine a relationship
between learning/memory and nociceptive behaviors. The first
experiment examined whether pre-existing learning impairment
induced by A-beta would change the course of nociceptive
behavior. The second experiment investigated whether the
established nociceptive response to ankle inflammation would
be reduced by intra-hippocampal injection of cycloheximide (a
protein synthesis inhibitor) that disrupted the related
nociceptive (pain) memory. Clinical studies indicate that pain
response is attenuated in patients with cognitive and learning
Figure 6.  Expression of PKCγ in the brain and spinal cord.  A–C) Immunostaining (A) and Western blot (B, C) showed an
upregulation of PKCγ in the hippocampus ipsilateral to ankle inflammation in rats with intra-hippocampal Aβ injection. Scale bar: 100
µm. B, C) In these same Aβ-injected rats, the PKCγ expression was downregulated in ipsilateral thalamus but not amygdala. In
addition, the expression of PKCγ was increased within the spinal cord dorsal horn ipsilateral to ankle inflammation in both intra-
hippocampal Aβ- or vehicle-injected rats. * P<0.05, as compared with the naïve and ACSF group on the same (ipsilateral) side.
doi: 10.1371/journal.pone.0074533.g006
Nociceptive Behavior and Leaning Impairment
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dysfunction such as AD [7,29–31], although we did not assess
performance of short versus long term memories in this study.
Nonetheless, our results support the notion that learning
impairment could alter the response to persistent nociception,
suggesting an important role of cognitive adaptation in the
mechanisms of chronic pain.
A number of preclinical models have been used to induce
learning impairment including Aβ1-40 and Aβ1-43 [32], Aβ1-40
alone [33], or Aβ1-42 alone [34] cerebral administration. In the
first experiment of this study, a mixture of Aβ1-40 and Aβ1-42
was used because it has been shown that a) initial deposition
of Aβ1-42 is an early pathological process of senile plaque in
the brain of AD, b) mature amyloid plaques were developed
following the further deposition of Aβ1-40, and c) the amount of
aggregated peptide correlates with the relative ratio of Aβ1-40
versus Aβ1-42 [32]. Consistently, lasting deposition of Aβ was
detected in the hippocampus in rats that received the Aβ
1-40/1-42 mixture. Of note is that, while exogenous Aβ was
injected into the hippocampus just to establish this model, its
expression would not indicate the endogenous Aβ level.
Moreover, these same rats showed a lower expression of
ChAT in the hippocampus, thalamus, and amygdala as
compared with vehicle-treated rats. Since ChAT is an enzyme
critical for acetylcholine synthesis, its downregulation suggests
Figure 7.  Disruption of persistent nociceptive behavior by cycloheximide.  A, C) Thermal hyperalgesia (A) and mechanical
allodynia (C) were developed on the ipsilateral hind paw of the rats with ankle inflammation when tested over a 5-day period
(designated as day -1 to -5). The statistical significance (ANOVA, P< 0.05; compared to the baseline) was not marked in the figure
for the first five days in order to simplify the presentation. Subsequently, rats treated with cycloheximide showed a swift recovery of
both thermal hyperalgesia and mechanical allodynia beginning on day 1 after cycloheximide injection. B, D) No differences in the
nociceptive threshold were detected between cycloheximide and vehicle groups on the contralateral hind paw of these same rats
over the entire experimental period. * P<0.05, ** P<0.01, as compared with baseline threshold of the same group. #P<0.05, # #
P<0.01, as compared with the cycloheximide group at the same time point. FWL: foot-withdrawal latency. White arrow: injection of
CFA into an ankle; Black arrows: injection of saline (1% DMSO in saline) or cycloheximide into the hippocampus.
doi: 10.1371/journal.pone.0074533.g007
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a loss of cholinergic neurons and a decrease in acetylcholine
release indicative of an early pathological process in AD [27].
Therefore, learning impairment induced by intra-hippocampal
Aβ injection mimics that demonstrated in preclinical models of
AD [8,9].
In the second experiment, intra-hippocampal injection of
cycloheximide was used to examine whether disruption of
learning and memory would influence the recovery of
nociceptive behavior. Cycloheximide has been shown to inhibit
protein synthesis in brain homogenates [35–37] and disrupt
learning and memory when administered to chicks in
conjunction with a reminder treatment [38]. The effect of
cycloheximide on learning and memory consolidation is likely
due to its role in blocking translation of polypeptide chains at
the elongation and termination phases and provoking the
accumulation of ribosome subunits on mRNA leading to
inhibition of the protein synthesis [39]. In this experiment,
disruption of learning and memory was independently
confirmed by the Morris water maze task in rats receiving
cycloheximide, but not vehicle, injection into bilateral
hippocampal CA1 area, which lasted for at least 19 days after
the cycloheximide treatment. Concurrently, the recovery of
nociceptive behavior was substantially shortened in those rats
treated with cycloheximide, suggesting that the function of
learning/memory is contributory to sustaining nociceptive
behavior in rats. It should be pointed out that chronic pain may
contribute to deficits in working memory without alterations in
long-term memory. Both models used in this study would affect
memory beyond the working memory phase. Moreover, we did
not specifically test performance of short versus long term
memories. These issues merit further investigation in future
studies.
A number of studies have shown that a state of dysfunctional
hippocampus such as that seen in AD due to Aβ deposition
could result in failure to recall the location of a hidden-platform
in a water maze [40–42]. Similar to the role of the hippocampus
in learning and memory, the amygdala participates in the
translation of cognitive input into neuroendocrine activity as
well [43]. Accordingly, lesions of the amygdala and
hippocampus produced emotional disturbances and learning
impairment [44,45]. On the other hand, thalamus is critical to
the central processing of nociceptive signals [46,47].
Consistent with an important functional role of hippocampus
and amygdala in cognition and learning, our results indicate
that the expression of NR1 and PKCγ was altered in these
brain regions in rats with Aβ-induced learning impairment.
It is well known that an upregulated expression of the NMDA
receptor and PKCγ is associated with persistent nociception
due to the initiation of intracellular cascades through calcium
influx [28,48,49]. Importantly, several studies have shown a
relationship between Aβ and NMDA receptor activity as well.
For example, 1) Aβ increases excitotoxicity mediated by
glutamate receptors including the NMDA receptor [50,51]; 2) a
low dose of Aβ can exacerbate a delayed cognitive impairment
caused by activation of the NMDA receptor [52]; and 3) Aβ-
induced excitotoxicity may be associated with the reduced
glutamate uptake [53] and/or increased glutamate release
[54,55]. Therefore, at least one of the mechanisms responsible
for the attenuation of thermal hyperalgesia and mechanical
allodynia in Aβ-injected rats might be related to a modulatory
role of Aβ on the NMDA receptor and PKCγ activity within
critical brain regions implicated in learning and perception of
nociceptive input. Future studies would elucidate the cellular
mechanisms of such interactions.
The present data suggest that a learning process may
promote cognitive maladaptation due to a state of persistent
nociception, which in turn could alter the perception of
nociceptive input. When such a learning process was
prevented and disrupted by the intra-hippocampal Aβ or
cycloheximide administration, the recovery of nociceptive
behavior was substantially shortened despite a state of
persistent nociception. While in this study disruption of the
hippocampal function by injecting either Aβ or cycloheximide
was shown to impact both memory and nociceptive behaviors,
Figure 8.  Learning impairment in naïve rats after intra-hippocampal cycloheximide.  Intra-hippocampal cycloheximide
injection (not saline) disrupted the established spatial learning (A: before the injection) in a parallel group of rats without ankle
inflammation, as shown in two separate series of the Morris water maze test (B: post-injection day 1-5 and C: post-injection day
15-19). *P< 0.05, as compared with the intra-hippocampal vehicle group.
doi: 10.1371/journal.pone.0074533.g008
Nociceptive Behavior and Leaning Impairment
PLOS ONE | www.plosone.org 11 September 2013 | Volume 8 | Issue 9 | e74533
it remains to be seen whether there is a reciprocal relationship
between transient memory impairment and pain experiences.
Nonetheless, these results suggest that pharmacological
and/or psychological interventions aimed at disrupting cognitive
maladaptation to a state of persistent nociception may be a
useful approach to preventing and treating chronic pain. Our
results also suggest that a preclinical model of combined
learning impairment and persistent nociception may be useful
to explore the brain mechanisms of the transition from acute to
chronic pain.
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